Cancer subtype | All subjects | Men | Women | ||||||
---|---|---|---|---|---|---|---|---|---|
N | HRa | P b | N | HRa | P c | N | HRa | P c | |
(95% CI) | (95% CI) | (95% CI) | |||||||
Total cancer incidence | 520 | 1.02 (0.93 to 1.12) | 0.611 | 257 | 1.08 (0.96 to 1.21) | 0.184 | 263 | 0.97 (0.86 to 1.11) | 0.705 |
Colon | 36 | 1.18 (0.90 to 1.55) | 0.238 | 19 | 1.49 (1.13 to 1.95) | 0.005** | 17 | 0.59 (0.31 to 1.13) | 0.108 |
Rectum | 34 | 1.16 (0.86 to 1.57) | 0.343 | 15 | 1.14 (0.71 to 1.83) | 0.583 | 19 | 1.15 (0.79 to 1.67) | 0.469 |
Lung and bronchi | 43 | 0.95 (0.68 to 1.33) | 0.764 | 23 | 0.95 (0.62 to 1.46) | 0.819 | 20 | 0.96 (0.59 to 1.54) | 0.864 |
Urinary tract | 36 | 0.87 (0.59 to 1.27) | 0.467 | 22 | 0.86 (0.55 to 1.35) | 0.515 | 14 | 0.93 (0.52 to1.68) | 0.815 |
Malignant melanoma | 22 | 1.00 (0.64 to 1.57) | 0.999 | 14 | 1.17 (0.74 to 1.87) | 0.499 | 8 | 0.64 (0.26 to 1.62) | 0.348 |
Skin (excluding melanoma) | 29 | 0.88 (0.65 to 1.45) | 0.879 | 19 | 1.12 (0.74 to 1.70) | 0.600 | 10 | 0.59 (0.25 to 1.38) | 0.225 |
Prostate | Â | Â | Â | 130 | 1.02 (0.86 to 1.21) | 0.841 | Â | Â | Â |
Breast | Â | Â | Â | Â | Â | Â | 122 | 1.00 (0.83 to 1.20) | 0.998 |